about
Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study.Antiplatelet effect of aspirin during 24h in patients with type 2 diabetes without cardiovascular disease.Plasma levels of MASP-1, MASP-3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene.High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes.Low Physical Activity Is Associated With Increased Arterial Stiffness in Patients Recently Diagnosed With Type 2 Diabetes.Detection of biomarkers using a novel proximity extension assay in patients with ST-elevation myocardial infarctionDifferential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetesVolumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls
P50
Q38820566-5C1CC960-A9C0-41A7-8B0A-A651DF2C7DC1Q45875018-1DAD1EFA-1890-4C8F-A550-5A2B1F7AC7DEQ48104524-745377C6-5A30-4C27-A377-9723BB0690D4Q50229865-F2B5AB36-0B5E-4860-9C83-F15B5CAEC688Q51585681-13E295B0-658E-4031-90B7-7CBCC90CAE6AQ57815710-35E07314-ACE4-4029-A0F9-19C22682157EQ90044354-819649CF-78A4-433F-B79C-43898BEAA1DBQ91326347-2C42C16B-2706-4460-80FD-E07A1CDB4EFC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Kristian L Funck
@en
Kristian L Funck
@nl
type
label
Kristian L Funck
@en
Kristian L Funck
@nl
prefLabel
Kristian L Funck
@en
Kristian L Funck
@nl
P31
P496
0000-0003-0213-5550